Elekta (OTCMKTS:EKTAY) Sees Large Volume Increase – Here’s Why

Posted by on Sep 26th, 2026

Shares of Elekta AB (OTCMKTS:EKTAY – Get Free Report) saw an uptick in trading volume on Thursday. Approximately 8,873 shares traded hands during trading, an increase of 209% from the previous session’s volume of 2,867 shares. The stock last traded at $5.08 and had previously closed at $5.1950.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 28th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Read Our Latest Stock Report on Elekta

Elekta Stock Performance

The company has a debt-to-equity ratio of 0.45, a current ratio of 0.86 and a quick ratio of 0.68. The company has a market capitalization of $1.87 billion, a P/E ratio of -42.37 and a beta of 1.05. The business has a 50-day moving average of $5.28 and a 200-day moving average of $5.58.

Elekta (OTCMKTS:EKTAY – Get Free Report) last issued its quarterly earnings results on Thursday, August 27th. The company reported $0.07 earnings per share for the quarter. The firm had revenue of $372.30 million for the quarter. Elekta had a positive return on equity of 13.47% and a negative net margin of 2.38%. On average, sell-side analysts anticipate that Elekta AB will post 0.43 EPS for the current year.

About Elekta

(Get Free Report)

Elekta AB is a Sweden-based medical technology company focused on radiation oncology and precision treatment solutions. The company develops and supplies systems used to diagnose, plan and deliver treatments for cancer and other conditions affecting the brain and nervous system.

Its product portfolio includes linear accelerators for external-beam radiotherapy, stereotactic radiosurgery systems such as Leksell Gamma Knife, brachytherapy equipment and treatment-planning, oncology information and workflow software.

Read More

Receive News & Ratings for Elekta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta and related companies with MarketBeat.com's FREE daily email newsletter.